Your Brain Tells Your Liver to Spike Blood Sugar When You're Stressed

Stress reliably raises blood sugar — a response long attributed to cortisol and adrenaline flooding the bloodstream. But a landmark study published in Nature from the Icahn School of Medicine at Mount Sinai reveals a fundamentally different mechanism: a direct neural circuit running from the medial amygdala (MeA) through the ventromedial hypothalamus (VMH) to the liver that drives rapid hyperglycemia during stress, entirely independently of classical stress hormones. This discovery reframes how we understand the brain's control of glucose metabolism and its connection to metabolic disease.

The researchers began by characterizing metabolic responses to acute stress in C57Bl/6 mice. Both physical restraint stress (30 minutes) and social stress (exposure to a conspecific male's odor in a territorialized cage) rapidly elevated blood glucose and impaired glucose tolerance. Restraint stress increased plasma corticosterone, adrenaline, glucagon, and glycerol, and upregulated hepatic G6pc (glucose-6-phosphatase) gene expression — a key enzyme in gluconeogenesis — without altering plasma insulin or noradrenaline. Critically, even 5-minute exposures to either stressor were sufficient to raise blood glucose and corticosterone, demonstrating the speed of the response.

Using FOS immunostaining and in vivo fiber photometry with GCaMP8s calcium sensors, the team showed that MeA neurons were rapidly and robustly activated by multiple stressor types — restraint, footshock, social odor, and even a visual threat (an approaching robotic 'robobug'). Importantly, MeA calcium signals rose before blood glucose increased, establishing the amygdala as an upstream driver rather than a downstream responder. MeA activity was not altered by novel clean cage exposure or locomotion, ruling out movement as a confound.

Chemogenetic activation of MeA neurons using excitatory hM3DGq DREADDs (CNO 3 mg/kg, intraperitoneal) significantly elevated blood glucose in unstressed mice without raising plasma corticosterone or adrenaline. This hyperglycemic effect persisted even when corticosterone synthesis was blocked with metyrapone, confirming that the MeA-driven glucose response is independent of HPA axis activation. Whole-body viral tracing identified a polysynaptic pathway from MeA neurons projecting to the VMH, which in turn connects to the liver via autonomic relays, promoting hepatic gluconeogenesis. Inhibition of MeA-to-VMH (MeA^VMH) neurons blunted stress-induced hyperglycemia, while their activation recapitulated it — along with hypophagia, mirroring the full metabolic stress response.

Perhaps most clinically significant, repeated stress exposure disrupted this circuit's normal function, producing a diabetes-like state of dysregulated glucose homeostasis. This provides a mechanistic link between chronic psychological stress and the development of type 2 diabetes — a relationship long observed epidemiologically but poorly understood at the circuit level. The study is currently limited to mouse models, and whether an analogous amygdala–liver axis operates in humans remains to be established. Nonetheless, the identification of this hormonally independent neural pathway opens new avenues for targeting stress-related metabolic dysfunction through brain-based interventions.